Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone and Ropivacaine for Rebound Pain After Thoracoscopic Surgery
NCT05825378Unknown
- Sponsor
- Beijing Tiantan Hospital
- Start
- May 2023
- Primary completion
- May 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexamethasone (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: The incidence of rebound pain after the disappearance of nerve block effect. Status: unknown.
02
Drugs
dexamethasone
Beyond the preview
Go deeper on NCT05825378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05825378.